TearLab Corp is an in-vitro diagnostic company. The Company commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film.
| Website: | www.tearlab.com |
| Email: | bdumencu@tearlab.com |
| Main Phone: | +1 858 455-6006 |
| Address: | 9980 Huennekens Street |
| Address 2: | Suite 100 |
| State: | CA |
| City / Town: | San Diego |
| Country: | USA |
| Postal Code: | 92121 |
| Exchange: | TSX |
| Employees: | 118 |
| NAICS: | In-Vitro Diagnos |
| Last Price 3.56 | Change $ 0.04 | Change % 1.14 | Tick N/A |
| Bid 3.50 | Bid Size 2,000.00 | Ask 3.85 | Ask Size 500.00 |
| Open 3.43 | High 3.87 | Low 3.24 | Prev Close 3.52 |
| Last Trade | Volume 38,400 | 52 Wk Hi 11.60 | 52 Wk Low 2.06 |
| Market Cap 20.4 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 5,735,732.00 | EPS (TTM) N/A | PE Ratio N/A | Exchange TSX |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 6 | 6 | 6 | 6 |
| Low Target Price Estimate | 6 | 6 | 6 | 6 |
| Mean Target Price Estimate | 6 | 6 | 6 | 6 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 11/13/12 | 11/13/12 | 11/13/12 | 11/13/12 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
